These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6360789)

  • 41. [Transient hyperprolactinemia during ovulation induction with gonadotropin releasing hormone (GnRH) pulsatile administration].
    Kuroda G; Tomioka N; Suginami H; Matsuura S
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 May; 39(5):785-91. PubMed ID: 3298470
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of gonadotropin-releasing hormone (GnRH) agonist on pituitary and ovarian responses to pulsatile GnRH therapy in polycystic ovarian disease.
    Surrey ES; de Ziegler D; Lu JK; Chang RJ; Judd HL
    Fertil Steril; 1989 Oct; 52(4):547-52. PubMed ID: 2680614
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Functional delineation of hyperprolactinemic-amenorrhea.
    Lachelin GC; Abu-fadil S; Yen SS
    J Clin Endocrinol Metab; 1977 Jun; 44(6):1163-74. PubMed ID: 406271
    [No Abstract]   [Full Text] [Related]  

  • 44. Pulsatile gonadotrophin releasing hormone therapy in patients with hyperandrogenaemia or hypothalamic amenorrhoea.
    Gerhard I; Hudea NH; Eggert-Kruse W; Runnebaum B
    Hum Reprod; 1988 Oct; 3(7):835-43. PubMed ID: 3053755
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pulsatile administration of gonadotrophin releasing hormone and oral administration of naltrexone in hypothalamic amenorrhoea.
    Leyendecker G; Waibel-Treber S; Wildt L
    Hum Reprod; 1993 Nov; 8 Suppl 2():184-8. PubMed ID: 8276957
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ovulation induction with intravenous gonadotropin-releasing hormone.
    Schivardi MR; Falsetti L; Omodei U; Scagliola P; Turla R; Gastaldi A
    Gynecol Endocrinol; 1989 Sep; 3(3):221-8. PubMed ID: 2686354
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Hypothalamic amenorrhea. Diagnostic and therapeutic values of pulsatile administration of gonadorelin].
    Fenichel P; Guedj AM; Verdino P; Brucker F; Strulo S; Mehouas C; Harter M
    Presse Med; 1988 Jan; 17(2):61-4. PubMed ID: 2964021
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Triplet pregnancy after pulsatile administration of gonadotropin releasing hormone.
    Bogchelman D; Lappöhn RE; Janssens J
    Lancet; 1982 Jul; 2(8288):45-6. PubMed ID: 6123775
    [No Abstract]   [Full Text] [Related]  

  • 49. Gonadotropinic reserve in women affected by hyperprolactinemic amenorrhea.
    Abate F; Oliva A; Baviera G; Martino P; Cannavò A; Leonardi R
    Clin Exp Obstet Gynecol; 1980; 7(2):126-30. PubMed ID: 7018740
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pregnancy following combined growth hormone--pulsatile GnRH treatment in a patient with hypothalamic amenorrhoea.
    Volpe A; Coukos G; Artini PG; Silferi M; Petraglia F; Boghen M; D'Ambrogio GD; Genazzani AR
    Hum Reprod; 1990 Apr; 5(3):345-7. PubMed ID: 2112557
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Induction of menstruation with bromocryptine in patients with euprolactinemic amenorrhea.
    Tolis G; Naftolin F
    Am J Obstet Gynecol; 1976 Oct; 126(4):426-9. PubMed ID: 990045
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ovulation induction and pregnancy in hypothalamic amenorrhea using self-administered intravenous gonadotropin-releasing hormone.
    Goerzen J; Corenblum B; Wiseman DA; Taylor PJ
    Fertil Steril; 1984 Feb; 41(2):319-21. PubMed ID: 6365602
    [No Abstract]   [Full Text] [Related]  

  • 53. Monitoring gonadotropin-releasing hormone administration by measurement of urinary steroid conjugates.
    De Vane GW; Czekala NM; Shideler SE; Riggall FC; Lasley BL
    Obstet Gynecol; 1986 May; 67(5):710-7. PubMed ID: 3515262
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Life table analysis of fecundity in intravenously gonadotropin-releasing hormone-treated patients with normogonadotropic and hypogonadotropic amenorrhea.
    Braat DD; Schoemaker R; Schoemaker J
    Fertil Steril; 1991 Feb; 55(2):266-71. PubMed ID: 1991525
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pulsatile delivery systems.
    Creasy GW; Jaffe ME
    Ann N Y Acad Sci; 1991; 618():548-57. PubMed ID: 2006808
    [No Abstract]   [Full Text] [Related]  

  • 56. Plasma prolactin levels and ovarian responsiveness to exogenous gonadotropins.
    Fraser IS; Markham R; Shearman RP
    Obstet Gynecol; 1978 May; 51(5):548-51. PubMed ID: 418368
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Closed intravenous administration of gonadotropin-releasing hormone: safety of extended peripheral intravenous catheterization.
    Hopkins CC; Hall JE; Santoro NF; Martin KA; Filicori M; Crowley WF
    Obstet Gynecol; 1989 Aug; 74(2):267-70. PubMed ID: 2664612
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Anomalies of the female sex organs--diagnosis and etiology of amenorrhea].
    Tanizawa O
    Nihon Rinsho; 1972 Nov; 30(11):2269-74. PubMed ID: 4119658
    [No Abstract]   [Full Text] [Related]  

  • 59. [Effects of a single intravenous injection, drip infusion and repeated subcutaneous injection of gonadotropin releasing hormone (Gn-RH)].
    Onuma S; Tamada T
    Horumon To Rinsho; 1976; 24(8):809-14. PubMed ID: 788967
    [No Abstract]   [Full Text] [Related]  

  • 60. Spontaneous return of menstruation in hypothalamic amenorrhea following gonadotropin-releasing hormone-induced pregnancy.
    Lewinthal D; Corenblum B; Brooks JH; Taylor PJ
    Fertil Steril; 1987 May; 47(5):870-1. PubMed ID: 3552754
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.